Genotyping in Sickle Cell Disease Patients: The French Strategy

Overview

Journal Transfus Med Hemother

Specialty Hematology

Date 2018 Oct 5

PMID 30283276

Citations 9

Authors

Aline Floch

Christophe Tournamille

Btissam Chami

France Pirenne

Affiliations

Soon will be listed here.

Abstract

This review presents the French strategy for blood group genotyping in high-responder and newly diagnosed sickle cell disease (SCD) patients. In addition to , , and genotyping, the RH blood group system is now explored in SCD patients in France. Molecular typing has been used for the deduction of partial RH2 (C) antigens since 2010, and the gradual implementation of systematic and genotyping nationwide was initiated in late 2014. In our laboratory, 962 RH:2 (C-positive) SCD patients have been tested since 2010, and 1,148 SCD patients of all RH phenotypes have been genotyped for clinically relevant alleles of and since late 2014.

Citing Articles

Resolution of Haplotype Ambiguities in Transfusion Settings.

Izard C, Laget L, Beley S, Bichel N, De Boisgrollier L, Picard C Int J Mol Sci. 2024; 25(11).

PMID: 38892055 PMC: 11172784. DOI: 10.3390/ijms25115868.

First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa.

Mbeti J, Benech C, Sack F, Wete E, Pangetha H, Ateba S Blood Transfus. 2024; 22(5):377-386.

PMID: 38315540 PMC: 11390615. DOI: 10.2450/BloodTransfus.660.

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.

Israelyan N, Vege S, Friedman D, Zhang Z, Uter S, Fasano R Transfusion. 2024; 64(3):526-535.

PMID: 38289184 PMC: 10947898. DOI: 10.1111/trf.17740.

Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion.

Floch A, Viret S, Malard L, Pakdaman S, Jouard A, Habibi A Blood Adv. 2023; 7(24):7608-7620.

PMID: 37699002 PMC: 10790094. DOI: 10.1182/bloodadvances.2022009328.

How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.

Pirenne F, Floch A, Habibi A Hematology Am Soc Hematol Educ Program. 2021; 2021(1):689-695.

PMID: 34889373 PMC: 8877235. DOI: 10.1182/hematology.2021000306.

References

Hemker M, Ligthart P, Berger L, van Rhenen D, van der Schoot C, Wijk P . DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood. 1999; 94(12):4337-42. View

Wagner F, Frohmajer A, Ladewig B, Eicher N, Lonicer C, Muller T . Weak D alleles express distinct phenotypes. Blood. 2001; 95(8):2699-708. View

Noizat-Pirenne F, Mouro I, Le Pennec P, Ansart-Pirenne H, Juszczak G, Patereau C . Two new alleles of the RHCE gene in Black individuals: the RHce allele ceMO and the RHcE allele cEMI. Br J Haematol. 2001; 113(3):672-9. DOI: 10.1046/j.1365-2141.2001.02802.x. View

Noizat-Pirenne F, Lee K, Le Pennec P, Simon P, Kazup P, Bachir D . Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood. 2002; 100(12):4223-31. DOI: 10.1182/blood-2002-01-0229. View

Storry J, Reid M, Fetics S, Huang C . Mutations in GYPB exon 5 drive the S-s-U+(var) phenotype in persons of African descent: implications for transfusion. Transfusion. 2003; 43(12):1738-47. DOI: 10.1046/j.0041-1132.2003.00585.x. View

Ong J, Walker P, Schmulbach E, Storry J, Vege S, Westhoff C . Alloanti-c in a c-positive, JAL-positive patient. Vox Sang. 2008; 96(3):240-3. PMC: 2754704. DOI: 10.1111/j.1423-0410.2008.01135.x. View

Lomas-Francis C, Alcantara D, Westhoff C, Uehlinger J, Valvasori M, Castilho L . JAL (RH48) blood group antigen: serologic observations. Transfusion. 2009; 49(4):719-24. PMC: 2756138. DOI: 10.1111/j.1537-2995.2008.02025.x. View

Flegel W, von Zabern I, Doescher A, Wagner F, Strathmann K, Geisen C . D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion. 2009; 49(6):1059-69. PMC: 10710224. DOI: 10.1111/j.1537-2995.2009.02102.x. View

Peyrard T, Pham B, Poupel S, Martin-Blanc S, Auxerre C, Kappler-Gratias S . Alloanti-c/ce in a c+ceAR/Ce patient suggests that the rare RHCE ceAR allele (ceAR) encodes a partial c antigen. Transfusion. 2009; 49(11):2406-11. DOI: 10.1111/j.1537-2995.2009.02308.x. View

10.

Pham B, Peyrard T, Tourret S, Beolet M, Many H, Juszczak G . Anti-HrB and anti-hrb revisited. Transfusion. 2009; 49(11):2400-5. DOI: 10.1111/j.1537-2995.2009.02307.x. View

11.

Tournamille C, Meunier-Costes N, Costes B, Martret J, Barrault A, Gauthier P . Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion. 2009; 50(1):13-9. DOI: 10.1111/j.1537-2995.2009.02382.x. View

12.

Westhoff C, Vege S, Halter-Hipsky C, Whorley T, Hue-Roye K, Lomas-Francis C . DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications. Transfusion. 2010; 50(6):1303-11. PMC: 2908519. DOI: 10.1111/j.1537-2995.2009.02573.x. View

13.

Hipsky C, Lomas-Francis C, Fuchisawa A, Reid M, Moulds M, Christensen J . RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford. Transfusion. 2010; 51(1):25-31. PMC: 2953576. DOI: 10.1111/j.1537-2995.2010.02764.x. View

14.

Halter Hipsky C, Lomas-Francis C, Fuchisawa A, Reid M . RHCE*ceAR encodes a partial c (RH4) antigen. Immunohematology. 2010; 26(2):57-9. View

15.

De Montalembert M, Dumont M, Heilbronner C, Brousse V, Charrara O, Pellegrino B . Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica. 2011; 96(6):801-7. PMC: 3105640. DOI: 10.3324/haematol.2010.038307. View

16.

Silvy M, Di Cristofaro J, Beley S, Papa K, Rits M, Richard P . Identification of RHCE and KEL alleles in large cohorts of Afro-Caribbean and Comorian donors by multiplex SNaPshot and fragment assays: a transfusion support for sickle cell disease patients. Br J Haematol. 2011; 154(2):260-70. DOI: 10.1111/j.1365-2141.2011.08691.x. View

17.

Hipsky C, Hue-Roye K, Lomas-Francis C, Huang C, Reid M . Molecular basis of the rare gene complex, DIVa(C)-, which encodes four low-prevalence antigens in the Rh blood group system. Vox Sang. 2011; 102(2):167-70. DOI: 10.1111/j.1423-0410.2011.01519.x. View

18.

Noizat-Pirenne F, Tournamille C . Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol. 2011; 18(5-6):527-35. DOI: 10.1016/j.tracli.2011.09.001. View

19.

Yazdanbakhsh K, Ware R, Noizat-Pirenne F . Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012; 120(3):528-37. PMC: 3401213. DOI: 10.1182/blood-2011-11-327361. View

20.

Reid M, Hipsky C, Hue-Roye K, Coghlan G, Olsen C, Lomas-Francis C . The low-prevalence Rh antigen STEM (RH49) is encoded by two different RHCE*ce818T alleles that are often in cis to RHD*DOL. Transfusion. 2012; 53(3):539-44. PMC: 3461235. DOI: 10.1111/j.1537-2995.2012.03754.x. View